China mRNA Synthesis & Manufacturing Market (2024-2029)
The China mRNA Synthesis & Manufacturing Market was valued at $67.61 Million in 2024 and projected to reach to $95.86 Million by 2029, representing a compound annual growth rate of 7.2%. China's mRNA synthesis and manufacturing market is poised for sustained growth through 2029, driven by government prioritization of biotechnology innovation and vaccine sovereignty.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
China mRNA Synthesis & Manufacturing Market Trends and Insights
- This 7.2% compound annual growth rate reflects China's strategic investments in biotechnology infrastructure and vaccine development capabilities.
- China is rapidly establishing itself as a critical hub for mRNA production, driven by government support for domestic pharmaceutical innovation and increasing demand for mRNA-based therapeutics across the region. The market growth in China is underpinned by substantial capital investments in manufacturing facilities and research institutions dedicated to mRNA technology.
- China's pharmaceutical sector is leveraging mRNA platforms to develop vaccines and personalized medicine solutions, positioning the country as a key player in the global mRNA landscape.
- Between 2024 and 2029, China is expected to strengthen its competitive position through technological advancement and scale-up of production capacity to meet both domestic and international demand..
Key Market Statistics
- CAGR (2024-2029) 7.2% CAGR
- Market Size, 2024 ~USD 67.61 Million
- Forecast, 2029 ~USD 95.86 Million
- Country China
China mRNA Synthesis & Manufacturing Market Overview
Market Valuation & Growth :
China's mRNA synthesis and manufacturing market reached $67.61 million in 2024, with a projected value of $95.86 million by 2029, representing a robust 7.2% CAGR—outpacing the global average of 5.8%.
Government-Backed Infrastructure :
Strategic government investments in biotechnology infrastructure and vaccine development capabilities are positioning China as a critical hub for mRNA production and establishing domestic manufacturing excellence.
Domestic Production Capabilities :
China is rapidly developing indigenous mRNA synthesis and manufacturing technologies to reduce dependency on imports and strengthen self-sufficiency in vaccine and therapeutic production.
Competitive Market Positioning :
With accelerating R&D initiatives and cost-competitive manufacturing advantages, China is emerging as a significant player in the global mRNA supply chain and contract manufacturing landscape.
China mRNA Synthesis & Manufacturing Market Dynamics
- The country's expanding manufacturing capacity, coupled with investments in advanced production facilities and skilled workforce development, will strengthen its position as a regional and global mRNA production hub. The market will benefit from increasing domestic demand for mRNA-based vaccines and therapeutics, alongside growing international partnerships and contract manufacturing opportunities.
- China's competitive cost structure and improving regulatory frameworks will attract both domestic biotech companies and international collaborators, further accelerating market expansion and technological advancement in mRNA synthesis capabilities..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Shimadzu Corporation
- Merck KGaA
Pharmaceuticals
- Bioreactors
- Analytical Testing
- Bioanalytical Testing Services
- Cell Counters
- Data Management Services
- Thermo Fisher Scientific Inc.
- SANOFI
- Merck KGaA
- NOVARTIS
- Pfizer Inc.
Key Takeaways
- China's mRNA synthesis and manufacturing market is valued at $67.61 million in 2024, with a projected value of $95.86 million by 2029.
- China is experiencing a 7.2% CAGR, outpacing the global average of 5.8%, indicating accelerated market growth and investment.
- China's government support for biotechnology and domestic pharmaceutical innovation is driving expansion of mRNA manufacturing infrastructure.
- China is positioning itself as a regional and global hub for mRNA production, with increasing capacity for vaccine and therapeutic development.
mRNA Synthesis & Manufacturing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MRNA SYNTHESIS & MODIFICATION SERVICES (Service) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5.8% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 2.23 (2024) |
| Revenue Forecast (Billions) | ~USD 2.96 (2029) |
| Segments Covered | Product, Type, Application, End User, Service, Consumables, Transcription Consumables, Purification Consumables, Analysis & Characterization Consumables |
China mRNA Synthesis & Manufacturing Market Report Segmentation
9 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Analysis & Characterization Consumables
- Analysis Kits And Reagents
- Chromatography Filters & Membrane
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Products
- Other Purification Consumables
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Purification Consumables
- Purification Kits & Reagents
- Rna Polymerases
- Transcription Consumables
- Vectors
By Application
- Cell & Gene Therapies
- Other Applications
- Vaccines
By End User
- Academic & Research Institutions
- Cros & Cdmos
- Cros And Cdmos
- Pharmaceutical & Biotechnology Companies
- Small-Scale Cros & Cdmos
By Service
- Manufacturing & Scale-Up Services
- Mrna Analysis & Characterization Services
- Mrna Purification Services
- Mrna Synthesis & Modification Services
By Consumables
- Analysis & Characterization Consumables
- Purification Consumables
- Transcription Consumables
By Transcription Consumables
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Rna Polymerases
- Vectors
By Purification Consumables
- Chromatography Filters & Membranes
- Other Purification Consumables
- Purification Kits & Reagents
- Purification Kits And Reagents
By Analysis & Characterization Consumables
- Analysis Kits & Reagents
- Analysis Kits And Reagents
- Other Analysis & Characterization Consumables
CHINA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 12.6 | 11.2 | 11.5 | 12.3 | 13.4 | 14.7 | 16.2 | 18.2 | 9.5 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 35.6 | 31.8 | 32.9 | 35.3 | 38.5 | 42.4 | 46.9 | 52.9 | 10 |
| SMALL-SCALE CROS & CDMOS | 4 | 3.5 | 3.6 | 3.8 | 4.1 | 4.4 | 4.8 | 5.4 | 8.6 |
| TOTAL | 52.2 | 46.4 | 48 | 51.4 | 56 | 61.5 | 68 | 76.5 | 9.8 |
CHINA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 23.8 | 17.8 | 18.4 | 19.5 | 20.9 | 22.4 | 24 | 26.1 | 7.3 |
| CROS & CDMOS | 19.2 | 14.4 | 14.8 | 15.6 | 16.8 | 18 | 19.3 | 20.9 | 7.2 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 55.7 | 41.8 | 43.2 | 45.8 | 49.2 | 52.9 | 56.8 | 61.8 | 7.4 |
| TOTAL | 98.6 | 74 | 76.3 | 80.9 | 86.9 | 93.3 | 100.1 | 108.8 | 7.4 |
Target Audience
- Pharmaceutical & Biotech Companies : Require detailed China market insights to evaluate manufacturing partnerships, contract production capabilities, and market entry strategies for mRNA therapeutics and vaccines.
- Investment & Private Equity Firms : Need validated market sizing and growth projections for China's mRNA sector to assess investment opportunities, portfolio company valuations, and exit potential in this high-growth market.
- Government & Policy Makers : Utilize market data to inform biotechnology policy development, infrastructure investment decisions, and strategic initiatives supporting China's mRNA manufacturing capabilities.
- Contract Manufacturing Organizations (CMOs) : Require market intelligence on China's mRNA manufacturing demand, competitive landscape, and capacity requirements to optimize service offerings and business development strategies.
- Supply Chain & Procurement Professionals : Need comprehensive data on China's mRNA synthesis capabilities, supplier ecosystem, and manufacturing costs to optimize sourcing strategies and supply chain resilience.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise valuation data for China's mRNA market ($67.61M in 2024) with verified 7.2% CAGR forecasts through 2029, enabling accurate investment and expansion planning decisions.
- Competitive Intelligence : Understand China's manufacturing capabilities, government support mechanisms, and competitive positioning relative to global markets to identify partnership and investment opportunities.
- Regulatory & Policy Insights : Access detailed analysis of China's biotechnology policies, vaccine development strategies, and manufacturing regulations shaping the mRNA market landscape and future growth drivers.
- Supply Chain Opportunities : Identify contract manufacturing partnerships, sourcing advantages, and supply chain integration opportunities within China's rapidly expanding mRNA production ecosystem.
- Strategic Market Entry : Leverage comprehensive China-specific market data to develop informed go-to-market strategies, joint venture frameworks, and localization approaches for mRNA-based products.
Frequently asked questions
What is the current size of China's mRNA synthesis and manufacturing market?
China's mRNA synthesis and manufacturing market was valued at $67.61 million in 2024 and is projected to reach $95.86 million by 2029.
What is the growth rate of China's mRNA market?
China's mRNA synthesis and manufacturing market is growing at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
What factors are driving growth in China's mRNA market?
Growth in China's mRNA market is driven by government support for biotechnology, investments in manufacturing infrastructure, vaccine development initiatives, and increasing demand for mRNA-based therapeutics.
How does China's mRNA market growth compare to global trends?
China's mRNA market is growing at 7.2% CAGR, which exceeds the global average of 5.8%, demonstrating China's accelerated adoption and investment in mRNA technology.
What is China's role in the global mRNA manufacturing landscape?
China is establishing itself as a critical regional and global hub for mRNA synthesis and manufacturing, with expanding production capacity and technological capabilities to serve domestic and international markets.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the mRNA synthesis and manufacturing market. Exhaustive secondary research was done to collect information on the mRNA synthesis and manufacturing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as market share analysis, MnM repository analysis, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the mRNA synthesis and manufacturing market.
Secondary Research
The market for the companies offering mRNA synthesis and manufacturing solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product & service portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. In the secondary research process, various secondary sources were referred to for identifying and collecting information related to the study. Secondary sources included annual reports, press releases, and investor presentations of blockchain vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and product-oriented perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global mRNA synthesis and manufacturing market scenario. Several primary interviews were conducted with market experts from both the demand side (such as personnel from the pharmaceutical & biopharmaceutical industry) and the supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, as well as channels) across five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, and online, personal, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Top-down approache was used to estimate and validate the total size of the mRNA synthesis and manufacturing market. These methods include market share analysis, MnM repository analysis were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research.
- The revenues generated from the mRNA synthesis and manufacturing market business of leading players have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
mRNA synthesis and manufacturing refers to the process of producing messenger RNA (mRNA) through in vitro transcription, followed by various purification, and characterization steps to create high-quality mRNA products suitable for research, therapeutic, or vaccine applications. The mRNA synthesis and manufacturing market encompasses the development, production, and commercialization of messenger RNA (mRNA) products, including their synthesis via in vitro transcription, large-scale manufacturing, and formulation. This market serves various applications such as vaccines, therapeutic treatments, and potentially other areas like protein replacement. It involves specialized technologies and equipment, adherence to regulatory standards, and a global supply chain network.
The study provides an in-depth analysis of the mRNA synthesis and manufacturing market based on contemporary market trends and developments, and its potential growth from 2024 to 2029. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key mRNA synthesis and manufacturing product and service providers.
Stakeholders
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Raw Material Suppliers
- Market Research and Consulting Firms
- Regulatory Agencies
- Venture Capitalists
- Government Organizations
- Industry Associations and Professional Societies
Report Objectives
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product, service, application, and region
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product by end user and service by end user
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the mRNA synthesis and manufacturing market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global mRNA synthesis and manufacturing market and comprehensively analyze their products and services portfolios, market positions, and core competencies.
- To track and analyze competitive developments such as product/service launches, expansions, agreements, and collaborations in the mRNA synthesis and manufacturing market
- To benchmark players within the mRNA synthesis and manufacturing market using the Company Evaluation Matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy
Get the Full mRNA Synthesis & Manufacturing Market Report
Full forecast, segment splits, and company analysis for all mRNA Synthesis & Manufacturing Market.
- Canada mRNA Synthesis & Manufacturing Market
- US mRNA Synthesis & Manufacturing Market
- Germany mRNA Synthesis & Manufacturing Market
- UK mRNA Synthesis & Manufacturing Market
- France mRNA Synthesis & Manufacturing Market
- Switzerland mRNA Synthesis & Manufacturing Market
- Italy mRNA Synthesis & Manufacturing Market
- Spain mRNA Synthesis & Manufacturing Market
- Japan mRNA Synthesis & Manufacturing Market
- India mRNA Synthesis & Manufacturing Market
- South Korea mRNA Synthesis & Manufacturing Market
- Brazil mRNA Synthesis & Manufacturing Market
- Rest Of Europe mRNA Synthesis & Manufacturing Market
- Rest Of Asia Pacific mRNA Synthesis & Manufacturing Market
- Rest Of Latin America mRNA Synthesis & Manufacturing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
